Francesca Longhena

1.6k total citations
33 papers, 1.1k citations indexed

About

Francesca Longhena is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Francesca Longhena has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Francesca Longhena's work include Parkinson's Disease Mechanisms and Treatments (25 papers), Neurological disorders and treatments (13 papers) and Alzheimer's disease research and treatments (8 papers). Francesca Longhena is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (25 papers), Neurological disorders and treatments (13 papers) and Alzheimer's disease research and treatments (8 papers). Francesca Longhena collaborates with scholars based in Italy, United Kingdom and United States. Francesca Longhena's co-authors include Arianna Bellucci, Gaia Faustini, Marina Pizzi, Cristina Missale, PierFranco Spano, Maria Grazia Spillantini, Michela Zaltieri, Luigi Bubacco, Nicola Biagio Mercuri and Annalena Venneri and has published in prestigious journals such as Journal of Cell Science, International Journal of Molecular Sciences and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Francesca Longhena

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Longhena Italy 20 641 385 342 262 181 33 1.1k
Amber D. Van Laar United States 16 716 1.1× 475 1.2× 445 1.3× 196 0.7× 158 0.9× 21 1.2k
Gaia Faustini Italy 18 552 0.9× 326 0.8× 276 0.8× 223 0.9× 172 1.0× 29 911
Karina Fog Denmark 18 789 1.2× 504 1.3× 478 1.4× 408 1.6× 295 1.6× 27 1.3k
Chee Yeun Chung United States 15 678 1.1× 656 1.7× 632 1.8× 282 1.1× 181 1.0× 20 1.4k
Eleanna Kara United Kingdom 17 729 1.1× 406 1.1× 322 0.9× 352 1.3× 259 1.4× 25 1.1k
Mattia Volta Italy 18 519 0.8× 416 1.1× 360 1.1× 227 0.9× 118 0.7× 27 953
Marion Delenclos United States 13 459 0.7× 247 0.6× 327 1.0× 289 1.1× 150 0.8× 20 890
Natalie Connor‐Robson United Kingdom 18 690 1.1× 371 1.0× 350 1.0× 261 1.0× 149 0.8× 26 1.0k
Chao Peng United States 7 742 1.2× 267 0.7× 369 1.1× 520 2.0× 274 1.5× 12 1.2k
Sonia George United States 17 759 1.2× 400 1.0× 345 1.0× 334 1.3× 329 1.8× 23 1.3k

Countries citing papers authored by Francesca Longhena

Since Specialization
Citations

This map shows the geographic impact of Francesca Longhena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Longhena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Longhena more than expected).

Fields of papers citing papers by Francesca Longhena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Longhena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Longhena. The network helps show where Francesca Longhena may publish in the future.

Co-authorship network of co-authors of Francesca Longhena

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Longhena. A scholar is included among the top collaborators of Francesca Longhena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Longhena. Francesca Longhena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Faustini, Gaia, et al.. (2023). Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?. Frontiers in Molecular Neuroscience. 16. 1197853–1197853. 24 indexed citations
3.
Calogero, Alessandra Maria, Francesca Longhena, Arianna Bellucci, et al.. (2023). Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization. International Journal of Molecular Sciences. 24(15). 12287–12287. 10 indexed citations
4.
Longhena, Francesca, Gaia Faustini, Giovanni Ribaudo, et al.. (2022). Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice. Pharmaceutics. 14(8). 1595–1595. 7 indexed citations
5.
Faustini, Gaia, Francesca Longhena, Anna Masato, et al.. (2022). Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype. Molecular Therapy. 30(4). 1465–1483. 14 indexed citations
6.
Longhena, Francesca, Gaia Faustini, Michele Sandre, et al.. (2022). Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease. Journal of Neuroinflammation. 19(1). 50–50. 63 indexed citations
7.
Bellucci, Arianna, Francesca Longhena, & Maria Grazia Spillantini. (2022). The Role of Rab Proteins in Parkinson’s Disease Synaptopathy. Biomedicines. 10(8). 1941–1941. 19 indexed citations
8.
Longhena, Francesca, et al.. (2021). An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders. Neuroscience & Biobehavioral Reviews. 130. 33–60. 29 indexed citations
9.
Faustini, Gaia, et al.. (2021). Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives. Frontiers in Immunology. 12. 611761–611761. 35 indexed citations
10.
Faustini, Gaia, Francesca Longhena, Agostino Bruno, et al.. (2020). Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate. Neurobiology of Disease. 138. 104789–104789. 22 indexed citations
11.
Longhena, Francesca, Valentina Straniero, Gaia Faustini, et al.. (2020). Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET‐Based Assay of Synapsin III Binding. ChemMedChem. 15(14). 1330–1337. 9 indexed citations
12.
Filippini, Alice, Gaia Faustini, Francesca Longhena, et al.. (2020). Extracellular clusterin limits the uptake of α‐synuclein fibrils by murine and human astrocytes. Glia. 69(3). 681–696. 37 indexed citations
13.
Bellucci, Arianna, Luigi Bubacco, Francesca Longhena, et al.. (2020). Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease. Frontiers in Aging Neuroscience. 12. 68–68. 65 indexed citations
14.
Longhena, Francesca, Gaia Faustini, & Arianna Bellucci. (2019). Study of alpha-synuclein fibrillation: state of the art and expectations. Neural Regeneration Research. 15(1). 59–59. 11 indexed citations
15.
Parrella, Edoardo, Arianna Bellucci, Vanessa Porrini, et al.. (2019). NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice. Translational Neurodegeneration. 8(1). 16–16. 22 indexed citations
16.
Longhena, Francesca, Gaia Faustini, Tatiana Varanita, et al.. (2018). Synapsin III is a key component of α‐synuclein fibrils in Lewy bodies of PD brains. Brain Pathology. 28(6). 875–888. 36 indexed citations
17.
Faustini, Gaia, Francesca Longhena, Tatiana Varanita, et al.. (2018). Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease. Acta Neuropathologica. 136(4). 621–639. 51 indexed citations
18.
Longhena, Francesca, Michela Zaltieri, Jéssica Grigoletto, et al.. (2017). Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons. Journal of Pharmacology and Experimental Therapeutics. 363(2). 164–175. 10 indexed citations
19.
Longhena, Francesca, PierFranco Spano, & Arianna Bellucci. (2017). Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases. Handbook of experimental pharmacology. 245. 85–110. 14 indexed citations
20.
Chiarelli, Nicola, Marina Colombi, Stefania Mitola, et al.. (2015). Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. Laboratory Investigation. 95(6). 585–602. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026